Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1994
Report date:
1994

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Version / remarks:
German BGA method (1991)
Deviations:
no
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
testing lab
Test type:
acute toxic class method

Test material

Constituent 1
Chemical structure
Reference substance name:
[1S-(1α,2β,3α,5α)]-[2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]methylamine
EC Number:
260-694-8
EC Name:
[1S-(1α,2β,3α,5α)]-[2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]methylamine
Cas Number:
57357-85-4
Molecular formula:
C11H21N
IUPAC Name:
1-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptan-3-yl]methanamine
Test material form:
liquid
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Lot No.of test material: 109 + 110/91

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: young adults
- Weight at study initiation: comparable
- Fasting period before study: ~16 h
- Housing: single-housed in stainless steel wire mesh cages, DK-III
- Diet: ad libitum, standardized animal laboratory diet
- Water: ad libitum, tab water
- Acclimation period: at least one week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 4 and 44 g/100 mL
- Justification for choice of vehicle: The test substance was insoluble in water.

MAXIMUM DOSE VOLUME APPLIED: 5 mL/kg
Doses:
200 (male and female animals), 2200 mg/kg (males only)
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 d
- Frequency of observations and weighing: General observation and mortalities was made twice each working day and once on weekends and on public holidays. Body weight determination was done shortly before administration (day 0), weekly thereafter and at the end of the study.
- Necropsy of survivors performed: Yes, at the last day of the observation period. Necropsy of all animals that died before as soon as possible.
- Other examinations performed: clinical signs, gross pathology

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 200 - < 2 200 mg/kg bw
Based on:
test mat.
Mortality:
Male animals: 200 mg/kg: no deaths; 2200 mg/kg: 3/3
Female animals: 200 mg/kg: no deaths; 2200 mg/kg: not tested
Clinical signs:
Signs of toxicity noted in the 2200 mg/kg bw dose group were: poor general state, dyspnoea, apathy, excitation, staggering, tremor, twitching, spastic gait, saltatory and flexion spasms, rolling convulsions, piloerection, and salivation.
The male animals of the 200 mg/kg bw dose group exhibited poor general state, dyspnoea, excitation, staggering, spastic gait, and piloerrection. They appeared normal 1 day after application.
The female animals of the 200 mg/kg bw dose group did not show any symptoms.
Body weight:
Male animals (200 mg/kg) : 179 g at study start, 271 g after 13 days
Female animals (200 mg/kg): 169 g at study start, 216 g after 13 days
Gross pathology:
Animals that died: diffuse reddening with blood extravasation into the lumen in the gastro-intestinal tract (2200 mg/kg: 3 males).
Sacrificed animals: no pathological findings noted (200 mg/kg; 3 males and 3 females)

Applicant's summary and conclusion

Interpretation of results:
Category 3 based on GHS criteria